Saini, K.S., Loi, S., de Azambuja, E., Metzger-Filho, O., Lamba Saini, M., Ignatiadis, M., et al. (2013) Targeting the PI3K/AKT/mTOR and Raf /MEK/ERK Pathways in the Treatment of Breast Cancer. Cancer Treatment Reviews, 39, 935-946.
https://doi.org/10.1016/j.ctrv.2013.03.009

has been cited by the following article:

• TITLE: Solanine Interferes with AKT/p-AKT and PI3K/p-PI3K Pathway to Inhibit HIF and Destroy Cell Energy Metabolism

  AUTHORS: Yidong Wang, Peng Wang, Wenbing Zhao

  KEYWORDS: Renal Carcinoma, Solanine, Energy Metabolism, PI3K/Akt Signaling Pathway, HIF-1 Alpha

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.9 No.10, October 20, 2021

  ABSTRACT: The purpose of this study was to explore the mechanism of Solanine disrupting energy metabolism in human renal cancer ACHN cells and to clarify its target. The specific method was to culture human renal cancer ACHN cell lines, and to intervene with Solanine of high, medium and low concentrations. The content of ATP in cells was measured by ELISA method. The expression of HIF-1α protein and the expression of PI3K, AKT, p-PI3K, p-AKT in PI3K/AKT pathway were detected by Western blotting. The results showed that compared with the control group, the relative expression of p-PI3K and p-AKT showed a downward trend with the increase of Solanine concentration (P 0.05). In addition, the relative expression of HIF-1α also showed a downward trend (P